-
Jun 11, 2020Meeting Launch date is Saturday, June 13th 2020 at 9:00am (PT)
-
Jun 1, 2020More than 1,140 patients randomized and topline results expected in second half 2020
-
May 18, 2020Pharmacokinetic comparison of STS101, an intranasal dry powder formulation of dihydroergotamine, with other intranasal, injectable and oral inhaled DHE formulations
-
May 12, 2020STS101 EMERGE™ Phase 3 efficacy trial remains on track with announcement of topline data expected in second half of 2020
-
Mar 10, 2020On track to announce topline data in second half of 2020 from Phase 3 EMERGE™ efficacy trial evaluating STS101 for the acute treatment of migraine